NDAINTRAVENOUSSOLUTION
Approved
Dec 2020
Lifecycle
Peak
Competitive Pressure
30/100
Data completeness
2/8 — Basic
GALLIUM GA 68 GOZETOTIDE (gallium ga-68 gozetotide) by Francis Medical is positron emitting activity [moa]. First approved in 2020.
Drug data last refreshed 14h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
GALLIUM GA-68 GOZETOTIDE is a positron-emitting radioactive diagnostic agent administered intravenously as a solution. It functions as a molecular imaging agent that enables positron emission tomography (PET) visualization of specific disease targets. The product is indicated for diagnostic imaging in oncology and other conditions where receptor-targeted imaging is clinically valuable.
Peak
Product is at peak commercial stage with moderate competitive intensity (30), indicating stable team investment in market penetration and account management.
Mechanism of Action
Positron Emitting Activity
Pharmacologic Class:
Radioactive Diagnostic Agent
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on GALLIUM GA-68 GOZETOTIDE offers stability within a mature, peak-stage diagnostic product with focused commercial and medical affairs responsibilities. Career progression favors deep expertise in nuclear medicine, imaging modalities, and healthcare provider relationships rather than clinical development pathways.
Medical Science Liaison
Worked on GALLIUM GA 68 GOZETOTIDE at Francis Medical? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.